Welcome to Our Medtech Talk Podcast Channel

Too often we define the Medtech sector by the number of dollars raised, IPOs helped or companies sold. But the focus neglects the very foundation of the sector - the People. Join the Medtech Talk Podcast each week to hear from entrepreneurs, investors and executives who spend their days developing the tools that make sick people well and health care more efficient.

Foundry’s Gifford: Innovating Innovation in a Changing Health Care World

April 23, 2015

Hanson Gifford of The Foundry reviews the evolving challenges behind Medtech innovation and shares details on Fire1 and Ardian.

Hanson S. Gifford III

Managing Member

The Foundry

Since 1998, Mr. Gifford has been a Managing Member of The Foundry, LLC. Its activities include the invention, identification and development of new technologies, and the formation, financing, and staffing of new companies. The Foundry has created Evalve (acquired by Abbott Labs), Concentric Medical (acquired by Stryker), Emphasys Medical, First to File, Satiety, Xtent (Nasdaq:XTNT), Cierra Medical, Ardian (acquired by Medtronic), Cabochon (acquired by Ulthera/Merz), Miramar Labs, Twelve, Holaira, Cotera, and Fire1. Mr. Gifford is also a founder of ForSight Labs, an ophthalmic device incubator which has started six companies. Prior to The Foundry, Mr. Gifford was VP of Research and Development at Heartport, Inc. (Nasdaq:HPRT) from 1993-1998. In 1992, Mr. Gifford was co-founder and managing director of Bavaria Medizin Technologie (BMT) GmbH. In 1991, Mr. Gifford served as President of CTT (acquired by Eli Lilly). From 1985-1990, Mr. Gifford worked at Devices for Vascular Intervention (acquired by Eli Lilly). Mr. Gifford is an inventor on over 225 issued US patents. He has a BSME from Cornell.